What"s in the Cards for Tanger (SKT) This Earnings Season?

Despite Tanger Factory Outlet Centers' (SKT) focus on improving tenant mix, amenities and marketing programs, its Q4 results might be affected by store closures, bankruptcies and lease modi.....»»

iQIYI (IQ) first-quarter 2019 results are likely to benefit from solid content slate and partnerships to boost its content reach and us.....»»

We expect AcelRx (ACRX) to provide update on the launch of its newly approved drug DSUVIA, when it reports first-quarter 2019 results. .....»»

Perrigo (PRGO) is focused on Consumer Healthcare Americas segment. Let's see if it aids the company's results in the soon-to-be reported qua.....»»

Given the expected strong earnings, investors may want to invest in .....»»

Better performance in Marke.....»»

Ensco's (ESV) first-quarter 2018 results to gain from higher rig operations in the prospective resources. However, cash flow is a concern. Ensco plc ESV is scheduled to report.....»»

Strong sales in Glaxo's (GSK) Pharmaceuticals and V.....»»

SAP SE (SAP) first-quarter 2018 earnings are likely to gain from cloud and softwa.....»»

Solid prospects of Roper's (ROP) Industrial Technology and Energy Systems & Controls segments are likely to boost the company.....»»

Earnings for Nucor's (NUE) steel m.....»»

Recent buyouts a.....»»

Pentair's (PNR) first-quarter results anticipated to benefit from strength in Enclosures and Process businesses despite volatile end markets. Pentair plc PNR is scheduled to report first-quarter 2018 results before the market op.....»»

Newfield's (NFX) f.....»»

Heightening competition from e-retailers expected to have impacted The Macerich Company's (MAC) Q1 performance, along with minimum rents and percentage rents remaining .....»»

Conatus' (CNAT) might see improvement in Q1 courtesy of its lead candidate emricasan. However, the company's portfolio is devoid of an approved product and its resulting revenues. Conatus Phar.....»»

Stronger performance at most business lines is likely to aid Assurant's (AIZ) Q1 earnings. Assurant, Inc. AIZ is slated to report first-quarter 2018 results on May 3 after the market closes.....»»

Investors are expected to focus on Rhopressa's launch.....»»

With no approved product in Geron's (GERN) portfolio, investor focus continues to remain on its sole pipeline candidate, imetelstat, ahead of the first-quarter earnings release. Geron Corporation GERN is expected to report fir.....»»

Inovio's (INO) most advanced pipeline candidate, VGX-3100's progress remains in focus. However, lack of an approved product in.....»»